Risk of endoscopic biliary interventions in primary sclerosing cholangitis is similar between patients with and without cirrhosis
Standard
Risk of endoscopic biliary interventions in primary sclerosing cholangitis is similar between patients with and without cirrhosis. / Peiseler, Moritz; Reiners, David; Pinnschmidt, Hans O; Sebode, Marcial; Jung, Franziska; Hartl, Johannes; Zenouzi, Roman; Ehlken, Hanno; Groth, Stefan; Schachschal, Guido; Rösch, Thomas; Weiler-Normann, Christina; Lohse, Ansgar W; Schramm, Christoph.
In: PLOS ONE, Vol. 13, No. 8, 2018.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Risk of endoscopic biliary interventions in primary sclerosing cholangitis is similar between patients with and without cirrhosis
AU - Peiseler, Moritz
AU - Reiners, David
AU - Pinnschmidt, Hans O
AU - Sebode, Marcial
AU - Jung, Franziska
AU - Hartl, Johannes
AU - Zenouzi, Roman
AU - Ehlken, Hanno
AU - Groth, Stefan
AU - Schachschal, Guido
AU - Rösch, Thomas
AU - Weiler-Normann, Christina
AU - Lohse, Ansgar W
AU - Schramm, Christoph
PY - 2018
Y1 - 2018
N2 - BACKGROUND: Endoscopic retrograde cholangiography (ERC) is a mainstay of therapy in patients with primary sclerosing cholangitis (PSC) and obstructive cholestasis. Patients with liver cirrhosis have an increased risk of surgical complications and are more susceptible to infections. Since PSC often progresses to cirrhosis, we aimed to assess whether ERC is associated with increased risk of complications in patients with PSC and cirrhosis.METHODS: Out of 383 patients with PSC, 208 patients received endoscopic treatment between 2009-2017. Seventy patients had cirrhosis when ERC was performed and 138 patients had no signs of cirrhosis. Overall, 663 ERC procedures were analysed, with 250 ERC in patients with cirrhosis and 413 ERC in patients without cirrhosis. Data were analysed retrospectively from a prospectively acquired database using repeated measures logistic regression.RESULTS: Overall, 40 procedure-related complications were documented in 663 ERC interventions (6%). The rate of complications was similar between patients with and without cirrhosis (4.4% vs. 7.0%). First-time ERC was associated with a higher risk of complications (17.5% vs. 4.9%). Biliary sphincterotomy, stent placement and female sex, but not presence of liver cirrhosis, were identified as risk factors for overall complications in multivariate analysis. Patients without cirrhosis showed a significant decline of ALP and bilirubin levels after the first two interventions. In contrast, in patients with cirrhosis, ALP and bilirubin levels did not significantly decline after ERC.CONCLUSIONS: In patients with PSC, cirrhosis was not a risk factor for post-ERC complications. Therefore, cirrhosis should not preclude endoscopic intervention in patients with clear clinical indication.
AB - BACKGROUND: Endoscopic retrograde cholangiography (ERC) is a mainstay of therapy in patients with primary sclerosing cholangitis (PSC) and obstructive cholestasis. Patients with liver cirrhosis have an increased risk of surgical complications and are more susceptible to infections. Since PSC often progresses to cirrhosis, we aimed to assess whether ERC is associated with increased risk of complications in patients with PSC and cirrhosis.METHODS: Out of 383 patients with PSC, 208 patients received endoscopic treatment between 2009-2017. Seventy patients had cirrhosis when ERC was performed and 138 patients had no signs of cirrhosis. Overall, 663 ERC procedures were analysed, with 250 ERC in patients with cirrhosis and 413 ERC in patients without cirrhosis. Data were analysed retrospectively from a prospectively acquired database using repeated measures logistic regression.RESULTS: Overall, 40 procedure-related complications were documented in 663 ERC interventions (6%). The rate of complications was similar between patients with and without cirrhosis (4.4% vs. 7.0%). First-time ERC was associated with a higher risk of complications (17.5% vs. 4.9%). Biliary sphincterotomy, stent placement and female sex, but not presence of liver cirrhosis, were identified as risk factors for overall complications in multivariate analysis. Patients without cirrhosis showed a significant decline of ALP and bilirubin levels after the first two interventions. In contrast, in patients with cirrhosis, ALP and bilirubin levels did not significantly decline after ERC.CONCLUSIONS: In patients with PSC, cirrhosis was not a risk factor for post-ERC complications. Therefore, cirrhosis should not preclude endoscopic intervention in patients with clear clinical indication.
KW - Journal Article
U2 - 10.1371/journal.pone.0202686
DO - 10.1371/journal.pone.0202686
M3 - SCORING: Journal article
C2 - 30125307
VL - 13
JO - PLOS ONE
JF - PLOS ONE
SN - 1932-6203
IS - 8
ER -
